Study identifies perception gap in incidence, impact of CINV/RINV
the ONA take:
There is a perpetual gap between healthcare professionals and patient perceptions of incidence and impact on patients' daily life of chemotherapy- and radiotherapy-induced nausea and vomiting (CINV/RINV), according to findings presented at the joint Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO) 2015 Annual Meeting on Supportive Care in Cancer in Copenhagen, Denmark.
Researchers found that oncologists and oncology nurses overestimate the incidence of CINV/RINV, but underestimate the effect that CINV/RINV has on patients' daily lives. Moreover, data showed that 28% of patients believe oncologists underestimate the impact of CINV/RINV on patients' daily lives.
Results also showed that physicians and nurses believe 60% of patients are fully compliant with physicians' and/or nurses guidelines for self-administration of anti-emetic medications; however, only 38% reported full compliance. Patients reported reluctance to increase pill burden and concern that swallowing would cause nausea/vomiting as reasons for non-compliance.
The findings suggest that the gap between physician and patient perceptions may result in inadequate management of patients' CINV/RINV.
There is a perpetual gap between healthcare professionals and patient perceptions of incidence and impact on patients' daily life of CINV/RINV.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- Overall Survival Prolonged With HIPEC + Cytoreductive Surgery for Gastric Cancer
- Better Postoperative Outcomes With RAMIE for Esophageal Cancer
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|